Загрузка компании
Just reported
Q4 FY2026 results
From Azenta's results release of 10 ноября 2026 г.. These are the company's first figures; its 10-Q or 10-K replaces them when filed.
Revenue
Actual
167,1M $
+5,0 % y/y
+3,7 % q/qGuided
—
No guide given
EPS, adjusted
Actual
0,28 $
Guided
—
No guide given
Operating income, GAAP
Actual
2,5M $
+32 % y/y
Guided
—
No guide given
Operating income, adjusted: 11,5M $
Company outlook
Full year 2027
- Revenue648M $ – 660M $First given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Keep exploring
The themes Azenta is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Highest-graded in Medical Instruments and Supplies
Graded A or B and worth $2B or more: A first, then the largest.
ISRGIntuitive Surgical, Inc.153,8B $A+
MDLNMedline Inc.51,9B $A
ALCAlcon Inc.36,1B $A
BLCOBausch & Lomb Corp7,5B $A-
ATRCAtriCure, Inc.2,9B $A
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 окт. 2026 г.CBGraded C, now B
MCKMckesson Corporation4 нояб. 2026 г.BAGraded B, now A
CVSCVS Health Corp4 нояб. 2026 г.BAGraded B, now A
EWEdwards Lifesciences Corporation4 нояб. 2026 г.BAGraded B, now A
GEHCGE Healthcare Technologies Inc.28 окт. 2026 г.CAGraded C, now A
Полная финансовая отчётность →
Построено по собственной отчётности Azenta, Inc., поданной в Комиссию по ценным бумагам и биржам США (SEC). Цифры — как отчиталась компания, история на акцию пересчитана на сегодняшнюю базу. Это описание бизнеса — не инвестиционная рекомендация и не совет что-либо покупать или продавать.
